Belzutifan induced strong responses in patients with von Hippel-Lindau disease-associated kidney cancer
HOUSTON ― Results from a Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center showed ...
Tag: Belzutifan
-
Asymptomatic SARS-CoV-2 infections responsible for spreading of COVID-19 less than symptomatic infections
-
Harsher COVID-19 restrictions associated with faster “pandemic fatigue”
-
Body weight influences the chance of developing Polycystic Ovary Syndrome
-
New survey illustrates challenges associated with healthcare environmental hygiene in facilities worldwide
-
New NYU Abu Dhabi research could make cancer treatments more efficient
-
University of Kentucky receives renewed $11.4 million grant to further cancer research